There is also evidence that A2M regulates tumor cell growth by upregulating PTEN and inhibiting tumour-promoting signalling pathways such as PI3K/AKT and SMAD, making A2M a promising anticancer drug which should also be further assessed [25]. This evidence concerns the gene AKT1 and neoplasm.